134 related articles for article (PubMed ID: 31598720)
1. Post-transplant lymphoproliferative disorder: risk factors and management.
Malyszko J
Nephrol Dial Transplant; 2019 Oct; ():. PubMed ID: 31598720
[No Abstract] [Full Text] [Related]
2. Post-transplant lymphoproliferative disease is associated with early sternotomy and left ventricular hypoplasia during infancy: a population-based retrospective review.
Ekman-Joelsson BM; Wåhlander H; Synnergren M; Sager M; Mellgren K
Cardiol Young; 2017 Nov; 27(9):1823-1831. PubMed ID: 28780922
[TBL] [Abstract][Full Text] [Related]
3. A French Cohort Study of Kidney Retransplantation after Post-Transplant Lymphoproliferative Disorders.
Caillard S; Cellot E; Dantal J; Thaunat O; Provot F; Janbon B; Buchler M; Anglicheau D; Merville P; Lang P; Frimat L; Colosio C; Alamartine E; Kamar N; Heng AE; Durrbach A; Moal V; Rivalan J; Etienne I; Peraldi MN; Moreau A; Moulin B;
Clin J Am Soc Nephrol; 2017 Oct; 12(10):1663-1670. PubMed ID: 28818847
[TBL] [Abstract][Full Text] [Related]
4. Incidence and mortality of post-transplant lymphoproliferative disorders after kidney transplantation: A real-world retrospective analysis in Japan.
Kato T; Yoshida T; Taniguchi A; Kawamura M; Nakazawa S; Namba-Hamano T; Yamanaka K; Abe T; Kishikawa H; Nonomura N; Imamura R
Int J Urol; 2022 Mar; 29(3):206-211. PubMed ID: 34897833
[TBL] [Abstract][Full Text] [Related]
5. Post-Transplant Lymphoproliferative Disorder in Kidney Transplant Recipients: A Single-Center Experience in Japan.
Ishihara H; Shimizu T; Unagami K; Hirai T; Toki D; Omoto K; Okumi M; Imai Y; Ishida H; Tanabe K
Ther Apher Dial; 2016 Apr; 20(2):165-73. PubMed ID: 26948427
[TBL] [Abstract][Full Text] [Related]
6. Occurrence of post-transplant lymphoproliferative disorders among over thousand adult recipients: any role for hepatitis C infection?
Burra P; Buda A; Livi U; Rigotti P; Zanus G; Calabrese F; Caforio A; Menin C; Canova D; Farinati F; Luciana Aversa SM
Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1065-70. PubMed ID: 16957512
[TBL] [Abstract][Full Text] [Related]
7. Primary central nervous system post-transplant lymphoproliferative disorder after allogeneic stem cell transplantation: a case report.
Tugend M; Dattero J; Shore T; Korobeynikov V; Sekula RF
Front Oncol; 2024; 14():1284577. PubMed ID: 38313803
[TBL] [Abstract][Full Text] [Related]
8. Post-transplant plasma cell myeloma and polymorphic lymphoproliferative disorder with monoclonal serum protein occurring in solid organ transplant recipients.
Sun X; Peterson LC; Gong Y; Traynor AE; Nelson BP
Mod Pathol; 2004 Apr; 17(4):389-94. PubMed ID: 14976525
[TBL] [Abstract][Full Text] [Related]
9. Use of EBV PCR for the diagnosis and monitoring of post-transplant lymphoproliferative disorder in adult solid organ transplant patients.
Tsai DE; Nearey M; Hardy CL; Tomaszewski JE; Kotloff RM; Grossman RA; Olthoff KM; Stadtmauer EA; Porter DL; Schuster SJ; Luger SM; Hodinka RL
Am J Transplant; 2002 Nov; 2(10):946-54. PubMed ID: 12482147
[TBL] [Abstract][Full Text] [Related]
10. EBV-negative monomorphic B-cell post-transplant lymphoproliferative disorders are pathologically distinct from EBV-positive cases and frequently contain TP53 mutations.
Courville EL; Yohe S; Chou D; Nardi V; Lazaryan A; Thakral B; Nelson AC; Ferry JA; Sohani AR
Mod Pathol; 2016 Oct; 29(10):1200-11. PubMed ID: 27443517
[TBL] [Abstract][Full Text] [Related]
11. Rare Case of Pediatric Post-transplant Lymphoproliferative Disorder Presenting With Pleural Masses Complicated by Pleural Effusions.
Nessim Kostandy E; Wan D; Imseis E
ACG Case Rep J; 2023 Sep; 10(9):e01158. PubMed ID: 37753100
[TBL] [Abstract][Full Text] [Related]
12. Contrast-enhanced ultrasound findings of post-transplant lymphoproliferative disorder in a transplanted kidney: A case report and literature review.
Lampe A; Duddalwar VA; Djaladat H; Aron M; Gulati M
J Radiol Case Rep; 2015 Oct; 9(10):26-34. PubMed ID: 26629291
[TBL] [Abstract][Full Text] [Related]
13. Post-transplant lymphoproliferative disorder presenting as epistaxis.
Clarke JD; Stock D; Singh V
J Laryngol Otol; 2004 Nov; 118(11):906-8. PubMed ID: 15638984
[TBL] [Abstract][Full Text] [Related]
14. Management and outcome of liver recipients with post-transplant lymphoproliferative disease.
Glez-Chamorro A; Jimenez C; Moreno-Glez E; Glez-Pinto I; Loinaz C; Gomez R; Garcia I; Alonso O; Palma F; Grande C
Hepatogastroenterology; 2000; 47(31):211-9. PubMed ID: 10690611
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for Epstein-Barr virus-related post-transplant lymphoproliferative disease after allogeneic hematopoietic stem cell transplantation.
Uhlin M; Wikell H; Sundin M; Blennow O; Maeurer M; Ringden O; Winiarski J; Ljungman P; Remberger M; Mattsson J
Haematologica; 2014 Feb; 99(2):346-52. PubMed ID: 24056821
[TBL] [Abstract][Full Text] [Related]
16. Gastrointestinal involvement of posttransplant lymphoproliferative disorder in lung transplant recipients: report of a case.
Shitrit D; Shitrit AB; Dickman R; Sahar G; Saute M; Kramer MR
Dis Colon Rectum; 2005 Nov; 48(11):2144-7. PubMed ID: 16086224
[TBL] [Abstract][Full Text] [Related]
17. [Post-transplantation lymphoproliferative disorder in childhood].
Stréhn A; Szőnyi L; Kriván G; Kovács L; Reusz G; Szabó A; Rényi I; Kovács G; Dezsőfi A
Orv Hetil; 2014 Feb; 155(8):313-8. PubMed ID: 24534879
[TBL] [Abstract][Full Text] [Related]
18. Management of Epstein-Barr Virus infections and post-transplant lymphoproliferative disorders in patients after allogeneic hematopoietic stem cell transplantation: Sixth European Conference on Infections in Leukemia (ECIL-6) guidelines.
Styczynski J; van der Velden W; Fox CP; Engelhard D; de la Camara R; Cordonnier C; Ljungman P;
Haematologica; 2016 Jul; 101(7):803-11. PubMed ID: 27365460
[TBL] [Abstract][Full Text] [Related]
19. Validation of a Post-Transplant Lymphoproliferative Disorder Risk Prediction Score and Derivation of a New Prediction Score Using a National Bone Marrow Transplant Registry Database.
Lee CC; Hsu TC; Kuo CC; Liu MA; Abdelfattah AM; Chang CN; Yao M; Li CC; Wu KH; Chen TC; Gau JP; Wang PN; Liu YC; Chiou LW; Lee MY; Li SS; Chao TY; Jou ST; Chang HH
Oncologist; 2021 Nov; 26(11):e2034-e2041. PubMed ID: 34506688
[TBL] [Abstract][Full Text] [Related]
20. Presence of monoclonal T-cell populations in B-cell post-transplant lymphoproliferative disorders.
Ibrahim HA; Menasce LP; Pomplun S; Burke M; Bower M; Naresh KN
Mod Pathol; 2011 Feb; 24(2):232-40. PubMed ID: 20834235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
